Page last updated: 2024-09-03

ak 2123 and Local Neoplasm Recurrence

ak 2123 has been researched along with Local Neoplasm Recurrence in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dobrowsky, W; Huigol, NG; Jayatilake, RS; Kagiya, VT; Kizilbash, NI; Okkan, S; Tatsuzaki, H	1

Trials

1 trial(s) available for ak 2123 and Local Neoplasm Recurrence

Article	Year
AK-2123 (Sanazol) as a radiation sensitizer in the treatment of stage III cervical cancer: results of an IAEA multicentre randomised trial. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2007, Volume: 82, Issue:1 Topics: Adult; Aged; Brachytherapy; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Radiation-Sensitizing Agents; Radiotherapy; Survival Analysis; Treatment Outcome; Triazoles; Uterine Cervical Neoplasms	2007

Article

Year

AK-2123 (Sanazol) as a radiation sensitizer in the treatment of stage III cervical cancer: results of an IAEA multicentre randomised trial.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2007, Volume: 82, Issue:1

Topics: Adult; Aged; Brachytherapy; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Radiation-Sensitizing Agents; Radiotherapy; Survival Analysis; Treatment Outcome; Triazoles; Uterine Cervical Neoplasms

2007